Lv3
260 积分 2023-10-11 加入
Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade
1天前
已关闭
An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer
27天前
已完结
Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity
1个月前
已关闭
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process
1个月前
已完结
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
4个月前
已完结
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
4个月前
已完结
Soluble CTLA-4 regulates immune homeostasis and promotes resolution of inflammation by suppressing type 1 but allowing type 2 immunity
5个月前
已完结
Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy
5个月前
已完结
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation
5个月前
已完结
Discovery of A Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads
9个月前
已完结
皖公网安备34019202002308
